The market was valued at USD 2.15 billion in 2025 and is projected to grow at a CAGR of 6.85% during the forecast period from 2026 to 2035. The shift toward minimally invasive procedures decreases recovery times, lowers complication rates, and encourages more patients to seek surgical intervention. Our healthcare research analyst, Deepa Pandey, analysed this value. She researched material types, clinical applications, regional growth drivers, and competitive landscapes. Her research is useful for medical product producers, healthcare providers, biotechnology firms, and investors for competitive benchmarking and strategic decision-making.
